Duration: 1 hour, 15 minutes
Available On Demand
In the wake of the COVID-19 pandemic, many non-COVID respiratory pathogens are demonstrating a resurgence. Influenza and respiratory syncytial virus (RSV) in particular are both demonstrating increasing positivity.
RSV is the most common single cause of respiratory hospitalization of infants and is the second largest cause of lower respiratory infection mortality worldwide. This year RSV rates are exceeding the usual number of cases, exacerbated by the immunity gap of the SARS-CoV-2 pandemic. As a result, healthcare resources are being stretched, creating new challenges.
This webinar will provide an overview of the current respiratory disease landscape from the perspective of clinicians working in diagnostics and patient care.
Our speakers will:
- Provide an update on COVID-19 testing and treatment trends
- Highlight clinical considerations for influenza and RSV resurgence post-pandemic
- Discuss what increasing positivity of non-COVID respiratory pathogens means for labs and healthcare systems this respiratory season